Biocryst Pharmaceuticals buy Evercore Inc.
Start price
18.02.26
/
50%
€6.00
Target price
18.02.27
€14.35
Performance (%)
30.43%
Price
02.04.26
€7.83
Summary
This prediction is currently active. The BUY prediction by Evercore_Inc_ for Biocryst Pharmaceuticals has seen massive gains of 30.43%. This prediction currently runs until 18.02.27. The prediction end date can be changed by Evercore_Inc_ at any time. Evercore_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -3.359% | -3.359% |
| iShares Core DAX® | 4.852% | -4.418% |
| iShares Nasdaq 100 | 3.999% | -3.283% |
| iShares Nikkei 225® | 4.221% | -6.223% |
| iShares S&P 500 | 3.324% | -3.174% |
Comments by Evercore_Inc_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat